The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Supernus Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Supernus Pharmaceuticals opposed by its competitors

Explore Supernus Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2552210
Dec 20, 2017Formulations Of Mazindol1
EP1589951
Aug 9, 2017Use Of A Mixture Of Two Or More Enteric Materials To Regulate Drug Release Via Membrane Or Matrix For Systemic Therapeutics1

Latest PTAB cases involving Supernus Pharmaceuticals

Discover the latest PTAB cases involving Supernus Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Supernus Pharmaceuticals

IPR2013-00368Jun 20, 2013AMNEAL PHARMACEUTICALSSUPERNUS PHARMACEUTICALSFinal Written Decision
IPR2013-00371Jun 20, 2013AMNEAL PHARAMCEUTICALSSUPERNUS PHARMACEUTICALSFinal Written Decision
IPR2013-00372Jun 20, 2013AMNEAL PHARAMCEUTICALSSUPERNUS PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Supernus Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SUPERNUS PHARMACEUTICALS - 2 - 3
AMNEAL PHARAMCEUTICALS - - 2 -
AMNEAL PHARMACEUTICALS - - 31 -
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB17 - - -